Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Neuroblastoma 44Ganglioneuroblastoma 5Medulloblastoma 4Glioblastoma 4Brain Neoplasms 4Gliosarcoma 3Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Rhabdoid Tumor 2Recurrence 2Pinealoma 2Oligodendroglioma 2Pyloric Stenosis, Hypertrophic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm, Residual 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1Ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Radiotherapy 5Melphalan 4Filgrastim 4Busulfan 4Topotecan 3Methylprednisolone 3Cyclophosphamide 3Carboplatin 3Vorinostat 2Voriconazole 2Thiotepa 2Therapeutics 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Itraconazole 2Flow Cytometry 2Early Intervention, Educational 2Antilymphocyte Serum 2Amplified Fragment Length Polymorphism Analysis 2trioctyl phosphine oxide 1sargramostim 1liposomal amphotericin B 1ispinesib 1imetelstat 1gallium nitrate 1fludarabine phosphate 1exatecan 1etoposide phosphate 1becatecarin 1alvocidib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dendritic Cell Sarcoma, Interdigitating × Isotretinoin × CNS × Clear all
NCT00217412 2014-06-17

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Neuroblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡